Get the most out of Ro­bot­ics Business Review!



This is an article excerpt. Please register to view the entire article.
Learn more about membership benefits or join and become a member today!

Accuray to Acquire TomoTherapy for $277 Million
image
The robotic radiosurgery provider will team with TomoTherapy to offer advanced treatments for cancer and other diseases.
By Cecilia Galvin


Accuray (Nasdaq: ARAY), a provider of robotic radiosurgery in Sunnyvale, Calif., and TomoTherapy Incorporated (Nasdaq: TOMO), creator of radiation therapy solutions for cancer care in Madison, Wisc., have signed a definitive agreement under which Accuray will acquire TomoTherapy for $4.80 per share in cash and stock, or a total of approximately $277 million.

The transaction combines technologies from two high-growth companies, which currently serve complementary patient populations that are treated by the same medical specialty.  The combined company will offer advanced patient-focused technologies for the treatment of cancer and other diseases, ranging from high-precision robotic radiosurgery for early-stage and localized disease…

To continue reading, join today.

Get started
Create your membership.
Already a member?





Comments
No comments yet. Be the first to post a comment.

Name:

Email:


View comment guidelines

Remember me

Notify me of follow-up comments?






3D-Printed UAVs Complete Preliminary UK Trials

Parker Hannifin Moves Forward with Indego Exoskeleton

Modular Robotics: A Scrappy Approach to Educational Robots

Factory Robots Get STAMINA Boost

How Honeybee’s Unexpected Meeting with NASA Changed Everything